3De Ridder F,De Maeseneer M,Stadnik T,et al.Severe adverse reactions with contrast agents for magnetic resonance:clinical experience in 30,000 MR examinations[J].JBR-BTR,2001,84(4):150-152. 被引量：1
4Niendorf HP,Dinger JC,Haustein J,et al.Tolerance data of Gd-DTPA:a review[J].Eur J Radiol ,1991,13(1):15-20. 被引量：1
5Chu WC,Lam WW,Metreweli C.Incidence of adverse events after I.V injection of MR contrast agents in a Chinese population.A comparison between gadopentetate and gadodiamide[J].Acta Radiol ,2000,41(6):662-666. 被引量：1
6Marti-Bonmati L,Vega T,Benito C,et al.Safety and efficacy of Omniscan (gadodiamide injection) at 0.1 mmol/kg for MRI in infants younger than 6 months of age:phase III open multicenter study[J].Invest Radiol,2000,35(2):141-147. 被引量：1
8Bloem JL,Wondergem J. Gd-DTPA as a contrast agent in CT[J].Radiology, 1989,171 (2) :578-579. 被引量：1
9Yaganti V, Alani F,Yaganti S,et al. Use of gadolinium for caro-tidartery angiography and stenting in patients with renal insuffi-ciency[J]. J Ren Care,2009,35(4) :211-218. 被引量：1
10Esteban JM,Alonso A, Cervera V, et al. One molar gadolinium-chelate (gadobutrol) as a contrast agent for CT angiography ofthethoracic and abdominal aorta [J]. Eur Radiol,2007,17 (9):2394-2400. 被引量：1
